Evidence map›Paper›PMID 36875499›Full record

ArticleInternational journal of reproductive biomedicine2023

Thymoquinone ameliorates acrylamide-induced reproductive toxicity in female rats: An experimental study.

Maryam Al-Ghamdi, Etimad Huwait, Nagwa Elsawi, Soad Shaker Ali, Ahmed Sayed

Open access · goldAbstract read
In one paragraph

Article in International journal of reproductive biomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Maryam Al-GhamdiDepartment of Biochemistry, Faculty of Science, King AbdulAziz University, Jeddah, Saudi Arabia.ORCID https://orcid.org/0000-0003-0861-953X
Etimad HuwaitDepartment of Biochemistry, Faculty of Science, King AbdulAziz University, Jeddah, Saudi Arabia.
Nagwa ElsawiDepartment of Chemistry, Lab Biochemistry, Faculty of Science, Sohag University, Sohag, Egypt.
Soad Shaker AliFaculty of Medicine, Merit University, Sohag, Egypt.
Ahmed SayedBiochemistry Laboratory, Faculty of Science, Chemistry Department, Assiut University, Assiut, Egypt.ORCID https://orcid.org/0000-0002-3349-2545
King Abdulaziz University · SAAssiut University · EGSohag University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acrylamide (AA) is a carcinogenic compound that causes severe reproductive impairments and represents a high environmental risk factor. Thymoquinone (TQ) has a unique antioxidant activity and has been widely used as a protective agent against various types of toxicity. Objective: To evaluate the protective effects of TQ against AA-induced reproductive toxicity in female rats. Materials and Methods: In this experimental study, 40 female albino rats (120-150 gr, 8-10 wk) were sorted into 4 groups, (n = 10/each), vehicle group (received a daily oral administration of 0.5 ml saline [9%]); AA group (received a daily oral administration with freshly prepared AA, 20 mg/kg body weight) for 21 days which is less than the lethal dose LD Results: TQ administration significantly enhanced the functional capacity of the ovary at hormones, oxidative biomarkers, and tumor markers at a significant level of p Conclusion: TQ showed a promising protective effect against AA-induced reproductive toxicity in female rats.

Indexed as

AcrylamideCyclooxygenase 2Inflammation.Oxidative stressRatsThymoquinone

Identifiers

PMID36875499
PMCPMC9982326
OpenAlexW4319598139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.